To the full analysis
Varex Imaging stock: growth
VREXVarex Imaging reported $844.6M in revenue for fiscal 2025, up 4.1% on the prior year, up 2.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2%
per year from 2013 to 2025, per share 1.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
−11.6%
per year from 2013 to 2025, per share −12.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2013 | |
|---|---|---|---|
| Revenue | 2.7% | 2.9% | 2.0% |
| Revenue per share | 1.4% | 2.1% | 1.3% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | −9.5% | −11.6% |
| Free cash flow per share | no data | −10.2% | −12.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2013 | $669.8M | $109.6M | $82.9M |
| 2014 | $685.2M | $110.1M | $95.4M |
| 2015 | $632.3M | $80M | $50.9M |
| 2016 | $620.1M | $68.5M | $45.3M |
| 2017 | $698.1M | $51.6M | $55M |
| 2018 | $773.4M | $27.5M | $64.9M |
| 2019 | $780.6M | $15.5M | $52.1M |
| 2020 | $738.3M | −$57.9M | −$10.3M |
| 2021 | $818.1M | $17.4M | $77.5M |
| 2022 | $859.4M | $30.3M | −$4.4M |
| 2023 | $893.4M | $47.4M | $87.7M |
| 2024 | $811M | −$47.7M | $20.4M |
| 2025 | $844.6M | −$70.3M | $18.8M |
Revenue by segment
How Varex Imaging Corporation makes its money and how that has shifted. Names are as the company reports them.
- Medical72%
- Industrial28%
Figures as a table
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Share 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Medical | $556.9M | $602M | $596.8M | $584.5M | $643.8M | $674.7M | $673.3M | $581.7M | 71.7% |
| Industrial | $141.2M | $171.4M | $183.8M | $153.8M | $174.3M | $184.7M | $220.1M | $229.3M | 28.3% |
| Total revenue | $698.1M | $773.4M | $780.6M | $738.3M | $818.1M | $859.4M | $893.4M | $811M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 3 Oct 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.